Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cellautotransplant: a retrospective study.
about
A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation.Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment.Oral mucositis: time for more studies.Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation.High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma.A phase I dose-escalation trial of high-dose melphalan with palifermin for cytoprotection followed by autologous stem cell transplantation for patients with multiple myeloma with normal renal function.Autologous hematopoietic progenitor cell transplantation for multiple myeloma through an outpatient program.Systematic review of amifostine for the management of oral mucositis in cancer patients.Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myeloma.An extract of Agaricus blazei Murill administered orally promotes immune responses in murine leukemia BALB/c mice in vivo.Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders.Infectious complications in breast cancer patients undergoing peripheral blood stem cell transplantation: a single center retrospective analysis towards outpatient strategy.Treatment of oral mucositis in hematologic patients undergoing autologous or allogeneic transplantation of peripheral blood stem cells: a prospective, randomized study with a mouthwash containing camelia sinensis leaf extract.Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma.A pilot study on feasibility and efficacy of amifostine preceding high-dose melphalan with autologous stem cell support in myeloma patients.Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma.High-dose therapy supported by autologous stem cell transplantation in patients with enteropathy-associated T-cell lymphoma.Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation.Trial of amifostine in autologous stem cell transplant.Very low toxicity and good quality of life in 48 elderly patients autotransplanted for hematological malignancies: a single center experience.
P2860
Q34190340-38F04012-A66A-4500-844C-AB37FE1E2AF3Q35079602-B5270A12-3A11-4C66-AD3C-857029722F97Q35173183-D61A1846-4E23-42E4-B961-C585277813DBQ36138187-4CED3F0C-4596-47E7-9519-09737FD29715Q36407446-A3AE7CC8-68C7-4C59-ACF2-E3FB9F8F6008Q37206924-B0148206-3B17-49A5-9130-D01FB01963FEQ38025703-142705A0-898F-4D7F-8D16-E0820677E87AQ38050986-EB20B717-A3DE-4A1C-8880-8028D116C1B9Q38095526-09A253E5-DCA5-41B1-86B6-4A14655B5A06Q39341304-E792DA53-C561-4C7E-87A5-3FA839A400EAQ40528386-B6860EA4-6EC4-427F-9985-C988C91F9EE0Q40590665-0D5055E1-D519-4C81-81E1-16764D67BE17Q43080886-93B5A253-CED0-458E-ABBE-47AD156BD790Q44221521-6B0DF96D-11DB-4644-BC4A-8F1203F64E54Q44248905-F707A25F-21AB-4286-A5A1-9B21B32F0F5CQ44758860-E168600D-E28A-456C-AA49-2CF2C2DE4000Q44762271-20D78A4F-4868-490A-BC36-AE8E8DF0C705Q46391449-6C9BF9F2-AB05-48CC-8180-5DAB607D8174Q46793139-FC396A21-4500-4194-949D-9A2CC5A5EE90Q53474437-01BE8E5E-202E-4C25-9D13-A3BAB9ADE0EA
P2860
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cellautotransplant: a retrospective study.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Amifostine can reduce mucosal ...... splant: a retrospective study.
@ast
Amifostine can reduce mucosal ...... splant: a retrospective study.
@en
type
label
Amifostine can reduce mucosal ...... splant: a retrospective study.
@ast
Amifostine can reduce mucosal ...... splant: a retrospective study.
@en
prefLabel
Amifostine can reduce mucosal ...... splant: a retrospective study.
@ast
Amifostine can reduce mucosal ...... splant: a retrospective study.
@en
P2093
P2860
P1476
Amifostine can reduce mucosal ...... splant: a retrospective study.
@en
P2093
De Souza C
Lucesole M
Massidda D
Montanari M
Offidani M
Olivieri A
P2860
P304
P356
10.1046/J.1365-2141.2000.02149.X
P407
P577
2000-08-01T00:00:00Z